Tzvia Bader, co-founder, and CEO talks about TrialJectory, a first-of-its-kind AI-powered platform that uses self-reported clinical data to match cancer patients with clinical trials and removes barriers to advanced treatment options. Tzvia is a cancer survivor and knows first hand what it’s like to be in search of the right clinical study. This service will allow all patients, regardless of where they are or their income level, to have access to the most up-to-date treatments.
Tzvia Bader, CEO and Co-Founder of TrialJectory is a savvy and experienced entrepreneur, with decades of experience in business development, product marketing and strategy. Prior to co-founding TrialJectory, Tzvia headed the global business unit at Amdocs where she was responsible for building a new product growth strategy, as well as for global sales and marketing. Tzvia was the founder and CEO of KIDDOapp, an iOS and Android-based family scheduling technological solution, and Vocativ, a start-up aiming at identifying fake news in social media using advanced analytics. Tzvia has held different business development and marketing positions in several tech companies, both B2B and B2C. She holds an Msc degree from the University of Nottingham, Nottingham, UK.